▶ 調査レポート

世界の非侵襲がん診断市場：市場規模・現状・予測
• 英文タイトル：Global Non-invasive Cancer Diagnosis Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。世界の非侵襲がん診断市場：市場規模・現状・予測 / Global Non-invasive Cancer Diagnosis Market Size, Status and Forecast 2019-2025 / QYR9N7685資料のイメージです。• レポートコード：QYR9N7685
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、91ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ
• 販売価格（消費税別）
  Single User￥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License￥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
当資料は、非侵襲がん診断のグローバル市場について調査・分析したレポートで、種類別（臨床化学、免疫化学/イムノアッセイ、分子診断、その他）、用途別（血液がん、固形腫瘍、乳がん、肺癌、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・非侵襲がん診断の世界市場規模
・主要企業別市場シェア
・非侵襲がん診断の世界市場規模：種類別（臨床化学、免疫化学/イムノアッセイ、分子診断、その他）
・非侵襲がん診断の世界市場規模：用途別（血液がん、固形腫瘍、乳がん、肺癌、その他）
・非侵襲がん診断のアメリカ市場規模（種類別、用途別）
・非侵襲がん診断のヨーロッパ市場規模（種類別、用途別）
・非侵襲がん診断の中国市場規模（種類別、用途別）
・非侵襲がん診断の日本市場規模（種類別、用途別）
・非侵襲がん診断の東南アジア市場規模（種類別、用途別）
・非侵襲がん診断のインド市場規模（種類別、用途別）
・非侵襲がん診断の中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・非侵襲がん診断の世界市場予測（2019年-2025年）
・非侵襲がん診断の地域別市場予測（2019年-2025年）
...

In 2018, the global Non-invasive Cancer Diagnosis market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.
This report focuses on the global Non-invasive Cancer Diagnosis status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Non-invasive Cancer Diagnosis development in United States, Europe and China.

The key players covered in this study
Gen-Probe Inc.
A&G Pharmaceutical
Affymetrix Inc.
Digene Corporation
Quest Diagnostics Inc.
BioView Inc.
LabCorp
AVIVA Biosciences Corporation
Precision Therapeutics

Market segment by Type, the product can be split into
Clinical Chemistry
Immunochemistry/Immunoassay
Molecular Diagnostics
Others

Market segment by Application, split into
Blood Cancer
Solid Tumors
Breast Cancer
Lung Cancer
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Non-invasive Cancer Diagnosis status, future forecast, growth opportunity, key market and key players.
To present the Non-invasive Cancer Diagnosis development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Non-invasive Cancer Diagnosis are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Non-invasive Cancer Diagnosis Market Size Growth Rate by Type (2014-2025)
1.4.2 Clinical Chemistry
1.4.3 Immunochemistry/Immunoassay
1.4.4 Molecular Diagnostics
1.4.5 Others
1.5 Market by Application
1.5.1 Global Non-invasive Cancer Diagnosis Market Share by Application (2014-2025)
1.5.2 Blood Cancer
1.5.3 Solid Tumors
1.5.4 Breast Cancer
1.5.5 Lung Cancer
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Non-invasive Cancer Diagnosis Market Size
2.2 Non-invasive Cancer Diagnosis Growth Trends by Regions
2.2.1 Non-invasive Cancer Diagnosis Market Size by Regions (2014-2025)
2.2.2 Non-invasive Cancer Diagnosis Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Non-invasive Cancer Diagnosis Market Size by Manufacturers
3.1.1 Global Non-invasive Cancer Diagnosis Revenue by Manufacturers (2014-2019)
3.1.2 Global Non-invasive Cancer Diagnosis Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Non-invasive Cancer Diagnosis Market Concentration Ratio (CR5 and HHI)
3.2 Non-invasive Cancer Diagnosis Key Players Head office and Area Served
3.3 Key Players Non-invasive Cancer Diagnosis Product/Solution/Service
3.4 Date of Enter into Non-invasive Cancer Diagnosis Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Non-invasive Cancer Diagnosis Market Size by Type (2014-2019)
4.2 Global Non-invasive Cancer Diagnosis Market Size by Application (2014-2019)

5 United States
5.1 United States Non-invasive Cancer Diagnosis Market Size (2014-2019)
5.2 Non-invasive Cancer Diagnosis Key Players in United States
5.3 United States Non-invasive Cancer Diagnosis Market Size by Type
5.4 United States Non-invasive Cancer Diagnosis Market Size by Application

6 Europe
6.1 Europe Non-invasive Cancer Diagnosis Market Size (2014-2019)
6.2 Non-invasive Cancer Diagnosis Key Players in Europe
6.3 Europe Non-invasive Cancer Diagnosis Market Size by Type
6.4 Europe Non-invasive Cancer Diagnosis Market Size by Application

7 China
7.1 China Non-invasive Cancer Diagnosis Market Size (2014-2019)
7.2 Non-invasive Cancer Diagnosis Key Players in China
7.3 China Non-invasive Cancer Diagnosis Market Size by Type
7.4 China Non-invasive Cancer Diagnosis Market Size by Application

8 Japan
8.1 Japan Non-invasive Cancer Diagnosis Market Size (2014-2019)
8.2 Non-invasive Cancer Diagnosis Key Players in Japan
8.3 Japan Non-invasive Cancer Diagnosis Market Size by Type
8.4 Japan Non-invasive Cancer Diagnosis Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Non-invasive Cancer Diagnosis Market Size (2014-2019)
9.2 Non-invasive Cancer Diagnosis Key Players in Southeast Asia
9.3 Southeast Asia Non-invasive Cancer Diagnosis Market Size by Type
9.4 Southeast Asia Non-invasive Cancer Diagnosis Market Size by Application

10 India
10.1 India Non-invasive Cancer Diagnosis Market Size (2014-2019)
10.2 Non-invasive Cancer Diagnosis Key Players in India
10.3 India Non-invasive Cancer Diagnosis Market Size by Type
10.4 India Non-invasive Cancer Diagnosis Market Size by Application

11 Central & South America
11.1 Central & South America Non-invasive Cancer Diagnosis Market Size (2014-2019)
11.2 Non-invasive Cancer Diagnosis Key Players in Central & South America
11.3 Central & South America Non-invasive Cancer Diagnosis Market Size by Type
11.4 Central & South America Non-invasive Cancer Diagnosis Market Size by Application

12 International Players Profiles
12.1 Gen-Probe Inc.
12.1.1 Gen-Probe Inc. Company Details
12.1.2 Company Description and Business Overview
12.1.3 Non-invasive Cancer Diagnosis Introduction
12.1.4 Gen-Probe Inc. Revenue in Non-invasive Cancer Diagnosis Business (2014-2019)
12.1.5 Gen-Probe Inc. Recent Development
12.2 A&G Pharmaceutical
12.2.1 A&G Pharmaceutical Company Details
12.2.2 Company Description and Business Overview
12.2.3 Non-invasive Cancer Diagnosis Introduction
12.2.4 A&G Pharmaceutical Revenue in Non-invasive Cancer Diagnosis Business (2014-2019)
12.2.5 A&G Pharmaceutical Recent Development
12.3 Affymetrix Inc.
12.3.1 Affymetrix Inc. Company Details
12.3.2 Company Description and Business Overview
12.3.3 Non-invasive Cancer Diagnosis Introduction
12.3.4 Affymetrix Inc. Revenue in Non-invasive Cancer Diagnosis Business (2014-2019)
12.3.5 Affymetrix Inc. Recent Development
12.4 Digene Corporation
12.4.1 Digene Corporation Company Details
12.4.2 Company Description and Business Overview
12.4.3 Non-invasive Cancer Diagnosis Introduction
12.4.4 Digene Corporation Revenue in Non-invasive Cancer Diagnosis Business (2014-2019)
12.4.5 Digene Corporation Recent Development
12.5 Quest Diagnostics Inc.
12.5.1 Quest Diagnostics Inc. Company Details
12.5.2 Company Description and Business Overview
12.5.3 Non-invasive Cancer Diagnosis Introduction
12.5.4 Quest Diagnostics Inc. Revenue in Non-invasive Cancer Diagnosis Business (2014-2019)
12.5.5 Quest Diagnostics Inc. Recent Development
12.6 BioView Inc.
12.6.1 BioView Inc. Company Details
12.6.2 Company Description and Business Overview
12.6.3 Non-invasive Cancer Diagnosis Introduction
12.6.4 BioView Inc. Revenue in Non-invasive Cancer Diagnosis Business (2014-2019)
12.6.5 BioView Inc. Recent Development
12.7 LabCorp
12.7.1 LabCorp Company Details
12.7.2 Company Description and Business Overview
12.7.3 Non-invasive Cancer Diagnosis Introduction
12.7.4 LabCorp Revenue in Non-invasive Cancer Diagnosis Business (2014-2019)
12.7.5 LabCorp Recent Development
12.8 AVIVA Biosciences Corporation
12.8.1 AVIVA Biosciences Corporation Company Details
12.8.2 Company Description and Business Overview
12.8.3 Non-invasive Cancer Diagnosis Introduction
12.8.4 AVIVA Biosciences Corporation Revenue in Non-invasive Cancer Diagnosis Business (2014-2019)
12.8.5 AVIVA Biosciences Corporation Recent Development
12.9 Precision Therapeutics
12.9.1 Precision Therapeutics Company Details
12.9.2 Company Description and Business Overview
12.9.3 Non-invasive Cancer Diagnosis Introduction
12.9.4 Precision Therapeutics Revenue in Non-invasive Cancer Diagnosis Business (2014-2019)
12.9.5 Precision Therapeutics Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Non-invasive Cancer Diagnosis Key Market Segments
Table Key Players Non-invasive Cancer Diagnosis Covered
Table Global Non-invasive Cancer Diagnosis Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Non-invasive Cancer Diagnosis Market Size Market Share by Type 2014-2025
Figure Clinical Chemistry Figures
Table Key Players of Clinical Chemistry
Figure Immunochemistry/Immunoassay Figures
Table Key Players of Immunochemistry/Immunoassay
Figure Molecular Diagnostics Figures
Table Key Players of Molecular Diagnostics
Figure Others Figures
Table Key Players of Others
Table Global Non-invasive Cancer Diagnosis Market Size Growth by Application 2014-2025 (Million US$)
Figure Blood Cancer Case Studies
Figure Solid Tumors Case Studies
Figure Breast Cancer Case Studies
Figure Lung Cancer Case Studies
Figure Others Case Studies
Figure Non-invasive Cancer Diagnosis Report Years Considered
Table Global Non-invasive Cancer Diagnosis Market Size 2014-2025 (Million US$)
Figure Global Non-invasive Cancer Diagnosis Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Non-invasive Cancer Diagnosis Market Size by Regions 2014-2025 (Million US$)
Table Global Non-invasive Cancer Diagnosis Market Size by Regions 2014-2019 (Million US$)
Table Global Non-invasive Cancer Diagnosis Market Share by Regions 2014-2019
Figure Global Non-invasive Cancer Diagnosis Market Share by Regions 2014-2019
Figure Global Non-invasive Cancer Diagnosis Market Share by Regions 2019
Table Market Top Trends
Table Global Non-invasive Cancer Diagnosis Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Non-invasive Cancer Diagnosis Market Share by Manufacturers (2014-2019)
Figure Global Non-invasive Cancer Diagnosis Market Share by Manufacturers in 2018
Table Global Non-invasive Cancer Diagnosis Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Non-invasive Cancer Diagnosis Product/Solution/Service
Table Date of Enter into Non-invasive Cancer Diagnosis Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Non-invasive Cancer Diagnosis Market Size by Type (2014-2019) (Million US$)
Table Global Non-invasive Cancer Diagnosis Market Size Share by Type (2014-2019)
Figure Global Non-invasive Cancer Diagnosis Market Size Market Share by Type (2014-2019)
Table Global Non-invasive Cancer Diagnosis Market Size by Application (2014-2019) (Million US$)
Table Global Non-invasive Cancer Diagnosis Market Size Share by Application (2014-2019)
Figure Global Non-invasive Cancer Diagnosis Market Size Market Share by Application (2014-2019)
Figure Global Non-invasive Cancer Diagnosis Revenue Market Share by Application in 2018
Figure United States Non-invasive Cancer Diagnosis Market Size 2014-2019 (Million US$)
Table United States Key Players Non-invasive Cancer Diagnosis Revenue (2018-2019) (Million US$)
Table United States Key Players Non-invasive Cancer Diagnosis Market Share (2018-2019)
Table United States Non-invasive Cancer Diagnosis Market Size by Type (2014-2019) (Million US$)
Table United States Non-invasive Cancer Diagnosis Market Share by Type (2014-2019)
Table United States Non-invasive Cancer Diagnosis Market Size by Application (2014-2019) (Million US$)
Table United States Non-invasive Cancer Diagnosis Market Share by Application (2014-2019)
Figure Europe Non-invasive Cancer Diagnosis Market Size 2014-2019 (Million US$)
Table Europe Key Players Non-invasive Cancer Diagnosis Revenue (2018-2019) (Million US$)
Table Europe Key Players Non-invasive Cancer Diagnosis Market Share (2018-2019)
Table Europe Non-invasive Cancer Diagnosis Market Size by Type (2014-2019) (Million US$)
Table Europe Non-invasive Cancer Diagnosis Market Share by Type (2014-2019)
Table Europe Non-invasive Cancer Diagnosis Market Size by Application (2014-2019) (Million US$)
Table Europe Non-invasive Cancer Diagnosis Market Share by Application (2014-2019)
Figure China Non-invasive Cancer Diagnosis Market Size 2014-2019 (Million US$)
Table China Key Players Non-invasive Cancer Diagnosis Revenue (2018-2019) (Million US$)
Table China Key Players Non-invasive Cancer Diagnosis Market Share (2018-2019)
Table China Non-invasive Cancer Diagnosis Market Size by Type (2014-20189) (Million US$)
Table China Non-invasive Cancer Diagnosis Market Share by Type (2014-2019)
Table China Non-invasive Cancer Diagnosis Market Size by Application (2014-2019) (Million US$)
Table China Non-invasive Cancer Diagnosis Market Share by Application (2014-2019)
Figure Japan Non-invasive Cancer Diagnosis Market Size 2014-2019 (Million US$)
Table Japan Key Players Non-invasive Cancer Diagnosis Revenue (2018-2019) (Million US$)
Table Japan Key Players Non-invasive Cancer Diagnosis Market Share (2018-2019)
Table Japan Non-invasive Cancer Diagnosis Market Size by Type (2014-2019) (Million US$)
Table Japan Non-invasive Cancer Diagnosis Market Share by Type (2014-2019)
Table Japan Non-invasive Cancer Diagnosis Market Size by Application (2014-2019) (Million US$)
Table Japan Non-invasive Cancer Diagnosis Market Share by Application (2014-2019)
Figure Southeast Asia Non-invasive Cancer Diagnosis Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Non-invasive Cancer Diagnosis Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Non-invasive Cancer Diagnosis Market Share (2018-2019)
Table Southeast Asia Non-invasive Cancer Diagnosis Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Non-invasive Cancer Diagnosis Market Share by Type (2014-2019)
Table Southeast Asia Non-invasive Cancer Diagnosis Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Non-invasive Cancer Diagnosis Market Share by Application (2014-2019)
Figure India Non-invasive Cancer Diagnosis Market Size 2014-2019 (Million US$)
Table India Key Players Non-invasive Cancer Diagnosis Revenue (2018-2019) (Million US$)
Table India Key Players Non-invasive Cancer Diagnosis Market Share (2018-2019)
Table India Non-invasive Cancer Diagnosis Market Size by Type (2014-2019) (Million US$)
Table India Non-invasive Cancer Diagnosis Market Share by Type (2014-2019)
Table India Non-invasive Cancer Diagnosis Market Size by Application (2014-2019) (Million US$)
Table India Non-invasive Cancer Diagnosis Market Share by Application (2014-2019)
Figure Central & South America Non-invasive Cancer Diagnosis Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Non-invasive Cancer Diagnosis Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Non-invasive Cancer Diagnosis Market Share (2018-2019)
Table Central & South America Non-invasive Cancer Diagnosis Market Size by Type (2014-2019) (Million US$)
Table Central & South America Non-invasive Cancer Diagnosis Market Share by Type (2014-2019)
Table Central & South America Non-invasive Cancer Diagnosis Market Size by Application (2014-2019) (Million US$)
Table Central & South America Non-invasive Cancer Diagnosis Market Share by Application (2014-2019)
Table Gen-Probe Inc. Company Details
Table Gen-Probe Inc. Revenue in Non-invasive Cancer Diagnosis Business (2014-2019) (Million US$)
Figure Gen-Probe Inc. Revenue Growth Rate in Non-invasive Cancer Diagnosis Business (2014-2019)
Table Gen-Probe Inc. Recent Development
Table A&G Pharmaceutical Company Details
Table A&G Pharmaceutical Revenue in Non-invasive Cancer Diagnosis Business (2014-2019)(Million US$)
Figure A&G Pharmaceutical Revenue Growth Rate in Non-invasive Cancer Diagnosis Business (2014-2019)
Table A&G Pharmaceutical Recent Development
Table Affymetrix Inc. Company Details
Table Affymetrix Inc. Revenue in Non-invasive Cancer Diagnosis Business (2014-2019)(Million US$)
Figure Affymetrix Inc. Revenue Growth Rate in Non-invasive Cancer Diagnosis Business (2014-2019)
Table Affymetrix Inc. Recent Development
Table Digene Corporation Company Details
Table Digene Corporation Revenue in Non-invasive Cancer Diagnosis Business (2014-2019)(Million US$)
Figure Digene Corporation Revenue Growth Rate in Non-invasive Cancer Diagnosis Business (2014-2019)
Table Digene Corporation Recent Development
Table Quest Diagnostics Inc. Company Details
Table Quest Diagnostics Inc. Revenue in Non-invasive Cancer Diagnosis Business (2014-2019)(Million US$)
Figure Quest Diagnostics Inc. Revenue Growth Rate in Non-invasive Cancer Diagnosis Business (2014-2019)
Table Quest Diagnostics Inc. Recent Development
Table BioView Inc. Company Details
Table BioView Inc. Revenue in Non-invasive Cancer Diagnosis Business (2014-2019)(Million US$)
Figure BioView Inc. Revenue Growth Rate in Non-invasive Cancer Diagnosis Business (2014-2019)
Table BioView Inc. Recent Development
Table LabCorp Company Details
Table LabCorp Revenue in Non-invasive Cancer Diagnosis Business (2014-2019)(Million US$)
Figure LabCorp Revenue Growth Rate in Non-invasive Cancer Diagnosis Business (2014-2019)
Table LabCorp Recent Development
Table AVIVA Biosciences Corporation Company Details
Table AVIVA Biosciences Corporation Revenue in Non-invasive Cancer Diagnosis Business (2014-2019)(Million US$)
Figure AVIVA Biosciences Corporation Revenue Growth Rate in Non-invasive Cancer Diagnosis Business (2014-2019)
Table AVIVA Biosciences Corporation Recent Development
Table Precision Therapeutics Company Details
Table Precision Therapeutics Revenue in Non-invasive Cancer Diagnosis Business (2014-2019)(Million US$)
Figure Precision Therapeutics Revenue Growth Rate in Non-invasive Cancer Diagnosis Business (2014-2019)
Table Precision Therapeutics Recent Development
Table Global Non-invasive Cancer Diagnosis Market Size by Regions (Million US$) 2019-2025
Figure Global Non-invasive Cancer Diagnosis Market Size Share by Regions (2019-2025)
Figure Global Non-invasive Cancer Diagnosis Market Size Share by Regions in 2025
Figure United States Non-invasive Cancer Diagnosis Market Size Forecast (2019-2025)(Million USD)
Figure Europe Non-invasive Cancer Diagnosis Market Size Forecast (2019-2025)(Million USD)
Figure China Non-invasive Cancer Diagnosis Market Size Forecast (2019-2025)(Million USD)
Figure Japan Non-invasive Cancer Diagnosis Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Non-invasive Cancer Diagnosis Market Size Forecast (2019-2025)(Million USD)
Figure India Non-invasive Cancer Diagnosis Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Non-invasive Cancer Diagnosis Market Size Forecast (2019-2025)(Million USD)
Table Global Non-invasive Cancer Diagnosis Market Size by Product (2019-2025) (Million US$)
Figure Global Non-invasive Cancer Diagnosis Market Size by Product (2019-2025)
Figure Global Non-invasive Cancer Diagnosis Market Size by Product in 2025
Table Global Non-invasive Cancer Diagnosis Market Size by Application (2019-2025) (Million US$)
Figure Global Non-invasive Cancer Diagnosis Market Size by Application (2019-2025)
Figure Global Non-invasive Cancer Diagnosis Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介
  • 世界の肺がんの診断と治療市場：市場規模・現状・予測
    Global Lung Cancer Diagnosis and Therapeutics Market Size, Status and Forecast 2019-2025
    QYR9N7483 2019年6月14日 103Pages
    当資料は、肺がんの診断と治療のグローバル市場について調査・分析したレポートで、種類別（非小細胞肺がん、小細胞肺がん）、用途別（病院、がん研究センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
  • 世界の中咽頭がんの診断と治療法市場：市場規模・現状・予測
    Global Oropharyngeal Cancer Diagnosis and Therapeutics Market Size, Status and Forecast 2019-2025
    QYR9N7722 2019年6月14日 99Pages
    当資料は、中咽頭がんの診断と治療法のグローバル市場について調査・分析したレポートで、種類別（内視鏡検査、生検、イメージング）、用途別（病院、外来手術センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
  • 世界の皮膚がんの診断と治療市場：市場規模・現状・予測
    Global Skin Cancer Diagnosis and Therapeutics Market Size, Status and Forecast 2019-2025
    QYR9N8050 2019年6月14日 104Pages
    当資料は、皮膚がんの診断と治療のグローバル市場について調査・分析したレポートで、種類別（日光角化症（AK）、ベース細胞がん（BCC）、扁平上皮がん（SCC）、メラノーマ）、用途別（病院、がん研究センター、診療所）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、...
  • 世界の前立腺がんの診断と治療市場：市場規模・現状・予測
    Global Prostate Cancer Diagnosis and Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7892 2019年6月14日 105Pages
    当資料は、前立腺がんの診断と治療のグローバル市場について調査・分析したレポートで、種類別（前立腺特異抗原検査（PSA）、直腸デジタル検査（DRE））、用途別（病院、診療所、研究センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報など...
  • 世界の黒色腫がん市場：市場規模・現状・予測
    Global Melanoma Cancer Market Size, Status and Forecast 2019-2025
    QYR9N7533 2019年6月14日 96Pages
    当資料は、黒色腫がんのグローバル市場について調査・分析したレポートで、種類別（非侵襲性黒色腫、浸潤性黒色腫）、用途別（病院、がん研究センター）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

    ...
  • 世界の肝炎検査診断市場：市場規模・現状・予測
    Global Hepatitis Test Diagnosis Market Size, Status and Forecast 2019-2025
    QYR9N7292 2019年6月14日 97Pages
    当資料は、肝炎検査診断のグローバル市場について調査・分析したレポートで、種類別（B型肝炎（HBV）、C型肝炎（HCV）、その他の肝炎疾患）、用途別（病院、老人ホーム、診断研究所、血液銀行、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企...
  • 世界のHIVの診断と治療市場：市場規模・現状・予測
    Global HIV Diagnosis and Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7303 2019年6月14日 95Pages
    当資料は、HIVの診断と治療のグローバル市場について調査・分析したレポートで、種類別（抗体検査、ウイルス同定アッセイ、Cd4テスト、ウイルス負荷試験、早期乳児診断）、用途別（診断研究所、病院、血液銀行、在宅ケアの設定）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場...
  • 世界の低侵襲美容施術市場：市場規模・現状・予測
    Global Minimally-Invasive Cosmetic Procedures Market Size, Status and Forecast 2019-2025
    QYR9N7579 2019年6月14日 96Pages
    当資料は、低侵襲美容施術のグローバル市場について調査・分析したレポートで、種類別（ボツリヌス毒素、軟組織フィラー、ケミカルピール、レーザー脱毛、マイクロダーマブレーション）、用途別（にきび＆外傷瘢痕、色素沈着過剰、脂肪組織の再生）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中...
  • 世界のてんかんの診断と治療市場：市場規模・現状・予測
    Global Epilepsy Diagnosis & Treatment Market Size, Status and Forecast 2019-2025
    QYR9N7167 2019年6月14日 92Pages
    当資料は、てんかんの診断と治療のグローバル市場について調査・分析したレポートで、種類別（診断（神経学的検査、血液検査、イメージング）、治療（投薬、手術））、用途別（病院、診療所）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれ...
  • 世界の低侵襲性脊椎圧迫骨折修復術市場：市場規模・現状・予測
    Global Minimally Invasive Vertebral Compression Fracture Repair Market Size, Status and Forecast 2019-2025
    QYR9N7578 2019年6月14日 99Pages
    当資料は、低侵襲性脊椎圧迫骨折修復術のグローバル市場について調査・分析したレポートで、種類別（椎体形成術デバイス、椎骨形成術デバイス）、用途別（病院、ASC）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
  • 世界の肺がんの診断と治療市場：市場規模・現状・予測世界の肺がんの診断と治療市場：市場規模・現状・予測 Lung cancer is a malignant lung tumor characterized by uncontrolled cell growth in tissues of the lung.Robust healthcare expenditure within the developed countries, increasing pollution, government initiatives for lung cancer, and rising cases of smoking are some of the major factors that fuel the g…
  • 世界の非侵襲的がん診断市場：市場規模・現状・予測世界の非侵襲的がん診断市場：市場規模・現状・予測 Non-invasive diagnosis is a procedure of identifying a disease without or with minimal incision of the body. These methods involve different techniques such as identifying genetic structure, biomarkers, changes in molecular biology, along with imaging technologies. Cancer is a disease related to gen…
  • 世界の肺がんの診断市場：市場規模・現状・予測世界の肺がんの診断市場：市場規模・現状・予測 Diagnosis of lung cancer depends on lung histology or sputum shedding cytology. Screening methods for lung cancer mainly include X-ray chest X-ray and sputum cytology, low-dose spiral CT, blood and sputum biomarkers, and exhalation gas monitoring.As people's awareness of cancer increases and technol…
  • 世界の中咽頭がんの診断と治療法市場：市場規模・現状・予測世界の中咽頭がんの診断と治療法市場：市場規模・現状・予測 Oropharyngeal cancer is a malignant tumour that starts in the cells of the oropharynx. Rising prevalence of oropharyngeal cancer has been the major factor driving the market growth. Additionally, increasing geriatric population and rising oropharyngeal cancer associated with them is another factor d…
  • 世界の皮膚がんの診断と治療市場：市場規模・現状・予測世界の皮膚がんの診断と治療市場：市場規模・現状・予測 Skin cancer is the uncontrolled development of anomalous skin cells.The major factor that drives the market is that when the sun rays that is the ultra violet rays comes in contact with skin may cause skin cancer. In 2018, the global Skin Cancer Diagnosis and Therapeutics market size was xx million …